General MedicationsINJECTIONStandard
DACTINOMYCIN
DACTINOMYCIN
Standard Dose
0.5MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview DACTINOMYCIN is listed in Drugs@FDA under application 213463 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient DACTINOMYCIN Form and strength INJECTABLE;INJECTION - 0.5MG/VIAL Sponsor MEITHEAL Submission history Latest submission status date: 2020-11-13 00:00:00.
Structured Monograph
Clinical summary
Approval overview DACTINOMYCIN is listed in Drugs@FDA under application 213463 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DACTINOMYCIN Form and strength INJECTABLE;INJECTION - 0.5MG/VIAL Sponsor MEITHEAL Submission history Latest submission status date: 2020-11-13 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.